You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 2, February 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Note
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Laryngology/ Speech/ Language Pathology
 •Neoplasms of Head & Neck
 •Alert me on articles by topic

Osteosarcoma of the Larynx

Jennifer K. Berge, MD; Silloo B. Kapadia, MD; Eugene N. Myers, MD

Arch Otolaryngol Head Neck Surg. 1998;124:207-210.

Malignant mesenchymal tumors of the larynx constitute 0.3% to 1% of all laryngeal cancers, and of these osteosarcoma is the rarest. Our review of the literature identified only 12 cases of osteosarcoma of the larynx, all of which occurred in men. Rarely, osteosarcoma of the larynx may follow radiation therapy for squamous cell carcinoma, or the larynx may be the site of metastatic osteosarcoma. We report a case of primary laryngeal osteosarcoma arising in the cricoid cartilage and the first case of osteosarcoma of the larynx occurring in a woman.


From the Departments of Otolaryngology–Head and Neck Surgery (Drs Berge and Myers) and Pathology (Dr Kapadia), University of Pittsburgh Medical Center, Pittsburgh, Pa.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Osteoblastoma of the Larynx: A Case Report
Ledeboer et al.
INT J SURG PATHOL 2005;13:365-367.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.